E-LIB Suche - Ergebnisse für: Charreau, I.

1

Épidémiologie de l'infection HHV8 chez les HSH prenant la P..:

Gras, J. ; Charreau, I. ; Minier, M....
Infectious Diseases Now. 51 (2021) 5 - p. S132 , 2021

Link: https://doi.org/10.1016/..

2

Archived HIV-1 DNA resistance mutations to rilpivirine and ..:

Gallien, S. ; Charreau, I. ; Nere, M. L....
Journal of Antimicrobial Chemotherapy. 70 (2014) 2 - p. 562-565 , 2014

Link: https://doi.org/10.1093/..

3

Comparison of resistance mutation patterns in historical pl..:

Delaugerre, C ; Braun, J ; Charreau, I...
HIV Medicine. 13 (2012) 9 - p. 517-525 , 2012

Link: https://doi.org/10.1111/..

4

H-34 Switch de l'enfuvirtide (ENF) pour le raltegravir (RAL..:

De Castro, N. ; Braun, J. ; Charreau, I....
Médecine et Maladies Infectieuses. 39 (2009) - p. S45 , 2009

Link: https://doi.org/10.1016/..

5

PIN32 COSTS OF INTERMITTENT VERSUS CONTINUOUS ANTIRETROVIRA..:

Charreau, I ; Jeanblanc, G ; Tangre, P...
Value in Health. 11 (2008) 6 - p. A438-A439 , 2008

Link: https://doi.org/10.1016/..

6

Oral contraceptive use and risk of benign breast disease in..:

Charreau, I ; Plu-Bureau, G ; Bachelot, A...
European Journal of Cancer Prevention. 2 (1993) 2 - p. 147-154 , 1993

Link: https://www.jstor.org/st..

7

Oral contraceptive use and risk of benign breast disease in..:

Charreau, I ; Plu-Bureau, G ; Bachelot, A...
European Journal of Cancer Prevention. 2 (1993) 2 - p. 147-154 , 1993

Link: https://doi.org/10.1097/..

8

First analysis on tumor regression for the European randomi..:

Chassagne, D. ; Charreau, I. ; Sancho-Garnier, H...
International Journal of Radiation Oncology*Biology*Physics. 22 (1992) 3 - p. 581-584 , 1992

Link: https://doi.org/10.1016/..

9

Progress report of a phase II and a phase III trial with et..:

Chassagne, D. ; Sancho-Garnier, H. ; Charreau, I...
Radiotherapy and Oncology. 20 (1991) - p. 121-127 , 1991

Link: https://doi.org/10.1016/..

10

Changes in kidney function among men having sex with men st..:

Liegeon, Geoffroy ; Antoni, Guillemette ; Pialoux, Gilles...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7035456/. , 2020

Link: http://www.ncbi.nlm.nih...

11

High Prevalence and High Rate of Antibiotic Resistance of M..:

Berçot, Béatrice ; Charreau, Isabelle ; Rousseau, Clotilde...
Clinical Infectious Diseases. 73 (2020) 7 - p. e2127-e2133 , 2020

Link: https://doi.org/10.1093/..

12

Effect of On-Demand Oral Pre-exposure Prophylaxis With Teno..:

Chaix, Marie-Laure ; Charreau, Isabelle ; Pintado, Claire...
Open Forum Infectious Diseases. 5 (2018) 11 - p. , 2018

Link: https://doi.org/10.1093/..

13

Étude de l'implication de l'oncostatine M dans la physiopat..:

Huguier, V. ; Giot, J.P. ; Levillain, P....
Annales de Dermatologie et de Vénéréologie. 142 (2015) 6-7 - p. S287 , 2015

Link: https://doi.org/10.1016/..

14

Bortezomib, C1-Inhibitor and Plasma Exchange Do Not Prolong..:

Le Bas-Bernardet, S. ; Tillou, X. ; Branchereau, J....
American Journal of Transplantation. 15 (2015) 2 - p. 358-370 , 2015

Link: https://doi.org/10.1111/..

15

Decreases in Inflammatory and Coagulation Biomarkers Levels..:

Silva, Erika F. ; Charreau, Isabelle ; Gourmel, Bernard...
The Journal of Infectious Diseases. 208 (2013) 6 - p. 892-897 , 2013

Link: https://doi.org/10.1093/..